Breast Cancer (HER2+, HER2-) Global Epidemiology Forecast to 2025 :
Feb 2, 2017
The Breast Cancer EpiCast Report provides an overview of the risk factors and global trends of NSCLC in the 8MM and Forecast to 2025.Report Written & Developed by Masters & PhD-level Epidemiologists.
February 2, 2017 /MarketersMedia/ —
Breast cancer is a malignant tumor that originates in the breast tissues. Most breast cancers are invasive tumors that have grown beyond the ducts or lobules of the breast and can metastasize to other parts of the body through the bloodstream and the lymphatic system. Invasive breast cancer in this analysis is defined as ICD-10 codes C50.0-50.9, while non-invasive DCIS breast cancer is defined as ICD-10 code D05.1; both types of breast cancer are based on country-specific, nationally representative sources. Uniform diagnostic criteria are used for all segmentations across the 8MM, where a breast biopsy was used to confirm cases of breast cancer. In addition, comparable staging criteria by the AJCC (American Joint Committee on Cancer) and UICC (Union for International Cancer Control) were applied across all 8MM.
Epidemiologists forecast that the diagnosed incident cases of invasive breast cancer (not including DCIS) in the 8MM for women will grow by an Annual Growth Rate (AGR) of 1.94% over the next 10 years, from 795,114 cases in 2015 to 949,161 cases in 2025. In 2015, the 60-69 year age group had the highest number of diagnosed incident cases of invasive breast cancer, contributing 195,701 (24.61%) cases of the total in the 8MM. Overall, the majority of diagnosed incident cases of breast cancer occurred in ages 40 years and older, accounting for 95.48% of all cases in the 8MM in 2015. The 8MM will see an increase in five-year diagnosed prevalent cases throughout the forecast period at an AGR of 2.39%, with 3,549,784 cases in 2015 and 4,399,243 in 2025. For HER2 status of diagnosed incident cases of invasive breast cancer in the 8MM throughout the forecast period, 17.53% of cases were HER2+, 68.07% were HER2-/HR+, and 14.40% were TN.
Complete report on Breast Cancer (HER2+, HER2-) - Epidemiology Forecast to 2025 spread across 99 pages is available at
http://www.reportsnreports.com/reports/798545-epicast-report-breast-cancer-her2-her2-epidemiology-forecast-to-2025.html
Epidemiologists utilized comprehensive, country-specific data from national breast cancer registries and peer-reviewed journal articles when available, to arrive at a meaningful, in-depth analysis and forecast for the diagnosed incident and five-year diagnosed prevalent cases of breast cancer. In this analysis, epidemiologists provide detailed, clinically relevant segmentations for diagnosed incident cases of breast cancer.
Request Sample
http://www.reportsnreports.com/contacts/requestsample.aspx?name=798545
Scope
• The Breast Cancer EpiCast Report provides an overview of the risk factors and global trends of NSCLC in the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and urban China). This report includes a forecast of non-invasive ductal carcinoma in situ (DCIS) breast cancer cases segmented by HER2 status. In addition, it includes a 10-year epidemiological forecast for the diagnosed incident cases and the five-year diagnosed prevalent cases of invasive breast cancer in women segmented by age (18 to 85 years and older) and HER2 status (HER2+/hormone receptor [HR]+, HER2+/HR-, HER2-/HR+, and HER2-/HR- triple negative [TN]). HER2+ invasive breast cancer cases are further segmented by stage at diagnosis, menopausal status, and site of metastasis; HER2-/HR+ invasive breast cancer cases are further segmented by stage at diagnosis, menopausal status, and biomarker expression; and TN invasive breast cancer cases are further segmented by stage at diagnosis and BRCA expression.
• The breast cancer epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
• The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
Reasons to buy
The Breast Cancer EpiCast report will allow you to -
• Develop business strategies by understanding the trends shaping and driving the global breast cancer market.
• Quantify patient populations in the global breast cancer market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for breast cancer therapeutics in each of the markets covered.
• Compare patient population potentials by HER2 status, menopausal status, and biomarker expression
Contact Info:
Name: Ritesh Tiwari
Email: [email protected]
Organization: ReportsnReports
Source URL: http://marketersmedia.com/breast-cancer-her2-her2-global-epidemiology-forecast-to-2025/158324
For more information, please visit http://www.reportsnreports.com/reports/798545-epicast-report-breast-cancer-her2-her2-epidemiology-forecast-to-2025.html
Source: MarketersMedia
Release ID: 158324
More News
Worried about losing creativity and other skills to AI? You’re not alone
Many of us fear AI weakens independent thought, creativity and learning, especially among young people who may rely on it to think for them.
This city slicker took a job in Darwin. What happened next surprised her
Long-time city dweller Emma Jane Edwards decided to move on whim 18 months ago.
They transformed the Espy. Now they want to revive a vacant Fitzroy pub
Five mates who launched a pub empire in their 20s have purchased a historic pub in Brunswick Street.
Why your closest friends probably won’t help you find a job
The surprising reality is that your next career move will probably emerge from the very edge of your orbit.
My accent is unremarkable. But it has almost certainly helped me
There’s a type of bias holding us back, economically and socially. Here’s how the way we speak might be shaping how people perceive us.
‘Hard to say there won’t be job cuts’, freshly arrived ABC news chief declares
In his first big day greeting staff, Simon Robinson did not confirm there would be job cuts, but pointedly avoided ruling out redundancies.
Qantas ground staff set to strike over ‘Joyce-era’ bargaining agreements
The 600 workers poised to go on strike are the last remaining Qantas ground workers, after 1800 of their colleagues were illegally sacked during the COVID pandemic.
‘They’re wolves’: Coles keeps milk prices higher despite axing farmer support
The supermarket giant started charging customers more when war broke out in the Middle East to support farmers. Now it and a Woolworths supplier have ended subsidies.
ASX gains as oil prices, bond yields ease; Big four banks advance
The Australian sharemarket has risen for the second day in a row after the Federal Reserve’s first interest rate rise in three years and a drop in oil prices.
Why AI hasn’t taken your job yet
The predicted AI job apocalypse hasn’t landed yet. But the industry is more concerned about the bigger problem of human extinction.
KPMG consultant admits to ‘gaps’ in its whistleblower report
A comprehensive report on KPMG’s whistleblower failings has come up short, as key staff weren’t interviewed and there were no records of crucial meetings.
Dalaroo survey lights up deep WA copper-nickel-PGE targets
Dalaroo Metals has homed in on priority drill targets at its Watheroo copper-nickel-PGE project in WA, after a new IP survey confirmed prior exploration indicators.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.